Literature DB >> 19874990

Prognostic value of myocardial infarct size and contractile reserve using magnetic resonance imaging.

Sebastian Kelle1, Stijntje D Roes, Christoph Klein, Thomas Kokocinski, Albert de Roos, Eckart Fleck, Jeroen J Bax, Eike Nagel.   

Abstract

OBJECTIVES: Our aim was to assess the predictive value of myocardial infarct size assessed with late gadolinium-enhanced (LGE) magnetic resonance imaging (MRI) in medically treated patients with chronic myocardial infarction relative to contractile reserve on low-dose dobutamine magnetic resonance (DSMR) for long-term event-free survival.
BACKGROUND: Information on the relative merits of scar tissue and contractile reserve to predict long-term prognosis in patients with chronic myocardial infarction is lacking.
METHODS: A total of 177 patients with known coronary artery disease and scar tissue on LGE MRI were enrolled. Left ventricular (LV) functional parameters at rest and during low-dose DSMR were assessed, and the wall motion score index was calculated.
RESULTS: Eleven patients (6.2%) suffered an event during follow-up (average 20.3 months). Infarct size was a stronger predictor of events than LV ejection fraction and LV volumes at rest and during low-dose DSMR. Myocardial infarct size was used to separate patients at high risk (spatial extent > or =6 segments, n = 98) from those at low risk (spatial extent <6 segments, n = 79) for mortality. In the subgroup of patients at high risk, transmurality of infarct was not a predictor of events. However, the presence of contractile reserve (n = 63) was associated with a significantly higher number of events (12.7%) compared with no change in wall motion score index (6.7%; n = 15; p = 0.008).
CONCLUSIONS: Myocardial infarct size on LGE MRI is a stronger predictor of clinical outcome than contractile reserve in medically treated patients with myocardial infarction. In patients with large myocardial scar, the presence of contractile reserve is more important for the prediction of events than scar tissue.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19874990     DOI: 10.1016/j.jacc.2009.07.027

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  50 in total

Review 1.  Cardiovascular magnetic resonance in heart failure.

Authors:  Theodoros D Karamitsos; Stefan Neubauer
Journal:  Curr Cardiol Rep       Date:  2011-06       Impact factor: 2.931

2.  Left ventricular ejection fraction and presence of myocardial necrosis assessed by cardiac magnetic resonance imaging correctly risk stratify patients with stable coronary artery disease: a multi-center all-comers trial.

Authors:  Dominik Buckert; Sebastian Kelle; Sebastian Buss; Grigorios Korosoglou; Rolf Gebker; Ralf Birkemeyer; Wolfgang Rottbauer; Hugo Katus; Burkert Pieske; Peter Bernhardt
Journal:  Clin Res Cardiol       Date:  2016-10-13       Impact factor: 5.460

3.  Myeloid-derived growth factor (C19orf10) mediates cardiac repair following myocardial infarction.

Authors:  Mortimer Korf-Klingebiel; Marc R Reboll; Stefanie Klede; Torben Brod; Andreas Pich; Felix Polten; L Christian Napp; Johann Bauersachs; Arnold Ganser; Eva Brinkmann; Ines Reimann; Tibor Kempf; Hans W Niessen; Jacques Mizrahi; Hans-Joachim Schönfeld; Antonio Iglesias; Maria Bobadilla; Yong Wang; Kai C Wollert
Journal:  Nat Med       Date:  2015-01-12       Impact factor: 53.440

4.  Role of biomarkers in assessment of early infarct size after successful p-PCI for STEMI.

Authors:  Gert Klug; Agnes Mayr; Johannes Mair; Michael Schocke; Michael Nocker; Thomas Trieb; Werner Jaschke; Otmar Pachinger; Bernhard Metzler
Journal:  Clin Res Cardiol       Date:  2011-01-04       Impact factor: 5.460

Review 5.  Cardiac MRI and Ischemic Heart Disease: Role in Diagnosis and Risk Stratification.

Authors:  Rahul N Sawlani; Jeremy D Collins
Journal:  Curr Atheroscler Rep       Date:  2016-05       Impact factor: 5.113

Review 6.  Cardiac MRI: a central prognostic tool in myocardial fibrosis.

Authors:  Bharath Ambale-Venkatesh; João A C Lima
Journal:  Nat Rev Cardiol       Date:  2014-10-28       Impact factor: 32.419

Review 7.  PET Assessment of Immune Cell Activity and Therapeutic Monitoring Following Myocardial Infarction.

Authors:  James T Thackeray
Journal:  Curr Cardiol Rep       Date:  2018-03-06       Impact factor: 2.931

8.  Intravenous Followed by X-ray Fused with MRI-Guided Transendocardial Mesenchymal Stem Cell Injection Improves Contractility Reserve in a Swine Model of Myocardial Infarction.

Authors:  Eric G Schmuck; Jill M Koch; Timothy A Hacker; Charles R Hatt; Michael T Tomkowiak; Karl K Vigen; Nicholas Hendren; Cathlyn Leitzke; Ying-Qi Zhao; Zhanhai Li; John M Centanni; Derek J Hei; Denise Schwahn; Jaehyup Kim; Peiman Hematti; Amish N Raval
Journal:  J Cardiovasc Transl Res       Date:  2015-09-15       Impact factor: 4.132

Review 9.  Imaging the myocardial ischemic cascade.

Authors:  Arthur E Stillman; Matthijs Oudkerk; David A Bluemke; Menko Jan de Boer; Jens Bremerich; Ernest V Garcia; Matthias Gutberlet; Pim van der Harst; W Gregory Hundley; Michael Jerosch-Herold; Dirkjan Kuijpers; Raymond Y Kwong; Eike Nagel; Stamatios Lerakis; John Oshinski; Jean-François Paul; Riemer H J A Slart; Vinod Thourani; Rozemarijn Vliegenthart; Bernd J Wintersperger
Journal:  Int J Cardiovasc Imaging       Date:  2018-03-19       Impact factor: 2.357

Review 10.  Noninvasive assessment myocardial viability: current status and future directions.

Authors:  Kevin C Allman
Journal:  J Nucl Cardiol       Date:  2013-06-15       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.